down arrow

Suzuken Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3398000004
  • TKS: 9987
JPY
5,268.00
-78 (-1.46%)

Sep 18

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Kyowa Kirin Co., Ltd.
Shionogi & Co., Ltd.
Ono Pharmaceutical Co., Ltd.
Otsuka Holdings Co., Ltd.
Nippon Shinyaku Co., Ltd.
Suzuken Co., Ltd.
Eisai Co., Ltd.
Santen Pharmaceutical Co., Ltd.
Hisamitsu Pharmaceutical Co., Inc.
Kobayashi Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Holdings Co., Ltd.

Why is Suzuken Co., Ltd. ?

1
Poor Management Efficiency with a low ROE of 5.93%
  • The company has been able to generate a Return on Equity (avg) of 5.93% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with a 2.77% CAGR growth in Net Sales over the last 5 years
  • The company has been able to generate a Return on Equity (avg) of 5.93% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 2.77% over the last 5 years
4
Flat results in Jun 26
  • INTEREST COVERAGE RATIO(Q) Lowest at 74,130
  • RAW MATERIAL COST(Y) Grown by 6.51% (YoY)
  • OPERATING PROFIT(Q) Lowest at JPY 7,413 MM
5
With ROE of 9.20%, it has a very attractive valuation with a 0.89 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -10.85%, its profits have risen by 2.7% ; the PEG ratio of the company is 0.9
6
Underperformed the market in the last 1 year
  • Even though the market (Japan Nikkei 225) has generated returns of 43.52% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -10.85% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Suzuken Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.77%
EBIT Growth (5y)
17.14%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.35
Sales to Capital Employed (avg)
5.85
Tax Ratio
29.75%
Dividend Payout Ratio
18.33%
Pledged Shares
0
Institutional Holding
0.39%
ROCE (avg)
13.69%
ROE (avg)
5.93%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.89
EV to EBIT
4.12
EV to EBITDA
3.03
EV to Capital Employed
0.76
EV to Sales
0.06
PEG Ratio
0.91
Dividend Yield
NA
ROCE (Latest)
18.54%
ROE (Latest)
9.20%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
ROCE(HY)

Highest at 9.23%

DEBTORS TURNOVER RATIO(HY)

Highest at 4.43 times

-8What is not working for the Company
INTEREST COVERAGE RATIO(Q)

Lowest at 74,130

RAW MATERIAL COST(Y)

Grown by 6.51% (YoY

OPERATING PROFIT(Q)

Lowest at JPY 7,413 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 1.18 %

PRE-TAX PROFIT(Q)

Lowest at JPY 5,070 MM

NET PROFIT(Q)

Lowest at JPY 3,347.25 MM

EPS(Q)

Lowest at JPY 49.99

Here's what is working for Suzuken Co., Ltd.

Debtors Turnover Ratio
Highest at 4.43 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Suzuken Co., Ltd.

Interest Coverage Ratio
Lowest at 74,130
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit
Lowest at JPY 7,413 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Operating Profit Margin
Lowest at 1.18 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at JPY 5,070 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit
Lowest at JPY 3,347.25 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (JPY MM)

EPS
Lowest at JPY 49.99
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (JPY)

Raw Material Cost
Grown by 6.51% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading